| Carrie Beth Wolf, CNM | |
|
5520 Park Ave Ste Wp2-700, Trumbull, CT 06611-3463 | |
| (203) 374-1018 | |
| (203) 396-0699 |
| Full Name | Carrie Beth Wolf |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 24 Years |
| Location | 5520 Park Ave Ste Wp2-700, Trumbull, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659488252 | NPI | - | NPPES |
| 004208444 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 000197 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
The battle against obesity, heart disease and other diet related health problems received a -4 Million boost today with the announcement of seven new research projects. The projects, taking place in universities and research institutes across the UK, are part of a partnership between two publicly-funded Research Councils and 15 companies.
In Wisconsin, the issue of access to reports on medical mistakes is part of a bill being considered in the state legislature. In Minnesota, physicians are seeking a delay to the plan to provide ratings based on cost and quality.
A Hunter-based prostate cancer support group says ground-breaking research by the University of Newcastle will help save many lives in the region. This new work has found patients with localized advanced prostate cancer can double their chances of survival by undertaking hormone therapy in combination with radiology treatment. This comes from a 10 year trial, coordinated by the University's Professor Jim Debnam.
Experts have identified new strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease. These recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.
› Verified 9 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20031215000455 |
News Archive
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
The battle against obesity, heart disease and other diet related health problems received a -4 Million boost today with the announcement of seven new research projects. The projects, taking place in universities and research institutes across the UK, are part of a partnership between two publicly-funded Research Councils and 15 companies.
In Wisconsin, the issue of access to reports on medical mistakes is part of a bill being considered in the state legislature. In Minnesota, physicians are seeking a delay to the plan to provide ratings based on cost and quality.
A Hunter-based prostate cancer support group says ground-breaking research by the University of Newcastle will help save many lives in the region. This new work has found patients with localized advanced prostate cancer can double their chances of survival by undertaking hormone therapy in combination with radiology treatment. This comes from a 10 year trial, coordinated by the University's Professor Jim Debnam.
Experts have identified new strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease. These recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carrie Beth Wolf, CNM 5520 Park Ave, Suite 302, Trumbull, CT 06611 Ph: (203) 374-1018 | Carrie Beth Wolf, CNM 5520 Park Ave Ste Wp2-700, Trumbull, CT 06611-3463 Ph: (203) 374-1018 |
News Archive
Progenics Pharmaceuticals, Inc. today presented the design and rationale of an ongoing phase 1 trial of its prostate-specific membrane antigen antibody drug conjugate (PSMA ADC) therapy at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO). This phase 1 trial is assessing the safety, tolerability and initial clinical activity of progressively increasing doses of PSMA ADC in patients with progressive, metastatic, hormone-refractory prostate cancer following prior taxane chemotherapy.
The battle against obesity, heart disease and other diet related health problems received a -4 Million boost today with the announcement of seven new research projects. The projects, taking place in universities and research institutes across the UK, are part of a partnership between two publicly-funded Research Councils and 15 companies.
In Wisconsin, the issue of access to reports on medical mistakes is part of a bill being considered in the state legislature. In Minnesota, physicians are seeking a delay to the plan to provide ratings based on cost and quality.
A Hunter-based prostate cancer support group says ground-breaking research by the University of Newcastle will help save many lives in the region. This new work has found patients with localized advanced prostate cancer can double their chances of survival by undertaking hormone therapy in combination with radiology treatment. This comes from a 10 year trial, coordinated by the University's Professor Jim Debnam.
Experts have identified new strategies for using electronic health records (EHRs) to treat patients with chronic kidney disease. These recommendations may help clinicians and hospitals better manage individual patients with chronic conditions and identify groups of patients most likely to benefit from different treatment strategies.
› Verified 9 days ago
Kimberly Ann Wierzchowski, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 115 Technology Dr Unit B107, Trumbull, CT 06611 Phone: 203-268-2239 | |
Melanie Albright, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5520 Park Ave, Suite 302, Trumbull, CT 06611 Phone: 203-374-1018 Fax: 203-396-0699 | |
Christa M Esposito, L.N.M. Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 5520 Park Ave, Suite 302, Trumbull, CT 06611 Phone: 203-374-1018 Fax: 203-396-0699 |